LM11A-31 for Progressive Supranuclear Palsy

PR
Overseen ByPTP Recruitment and Retention (RER) Team
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Adam Boxer
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP. Regimen B will evaluate the safety and efficacy of a single study drug, LM11A-31, in participants with PSP.

Who Is on the Research Team?

AW

Anne-Marie Wills, MD

Principal Investigator

Massachusetts General Hospital

AB

Adam Boxer, MD, PhD

Principal Investigator

University of California, San Francisco

IL

Irene Litvan, MD

Principal Investigator

University of California, San Diego

JR

Julio Rojas-Martinez, MD, PhD

Principal Investigator

University of California, San Francisco

Are You a Good Fit for This Trial?

This trial is for people diagnosed with possible or probable Progressive Supranuclear Palsy (PSP) Richardson's Syndrome, who have had symptoms for 5 years or less. Participants must be able to walk at least 10 steps with minimal help, live at home or in the community, and have good enough vision, hearing, and thinking skills to take part.

Inclusion Criteria

My mental state score is 25 or higher.
I have been diagnosed with possible or probable PSP Richardson's Syndrome.
I live at home or in a community setting, including assisted living.
See 4 more

What Are the Treatments Tested in This Trial?

Interventions

  • LM11A-31

Trial Overview

The study is testing a new drug called LM11A-31 compared to a placebo (inactive pill) in people with PSP. The goal is to see if LM11A-31 is safe and effective. Participants are randomly assigned to receive either the drug or placebo.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: Regimen B: LM11A-31Experimental Treatment1 Intervention
Group II: Matching PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Adam Boxer

Lead Sponsor

Trials
2
Recruited
50+

Alzheimer's Therapeutic Research Institute

Collaborator

Trials
18
Recruited
58,400+

PharmatrophiX Inc.

Industry Sponsor

Trials
1
Recruited
240+

Massachusetts General Hospital

Collaborator

Trials
3,066
Recruited
13,430,000+

University of Southern California

Collaborator

Trials
956
Recruited
1,609,000+

University of California, San Diego

Collaborator

Trials
1,215
Recruited
1,593,000+

Alzheimer's Clinical Trials Consortium

Collaborator

Trials
5
Recruited
2,800+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+